Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials

Jan Beyer-Westendorf; Anthonie W. A. Lensing; Roopen Arya; Henri Bounameaux; Alexander T. Cohen; Philip S. Wells; Saskia Middeldorp; Peter Verhamme; Rodney Hughes; Nils Kucher; Akos F. Pap; Mila Trajanovic; Martin H. Prins; Paolo Prandoni; Jeffrey I. Weitz

doi:10.1016/j.thromres.2016.11.014

Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials

Jan Beyer-Westendorf^*, Anthonie W. A. Lensing, Roopen Arya, Henri Bounameaux, Alexander T. Cohen, Philip S. Wells, Saskia Middeldorp, Peter Verhamme, Rodney Hughes, Nils Kucher, Akos F. Pap, Mila Trajanovic, Martin H. Prins, Paolo Prandoni, Jeffrey I. Weitz

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	29-37
Number of pages	9
Journal	Thrombosis Research
Volume	149
DOIs	https://doi.org/10.1016/j.thromres.2016.11.014
Publication status	Published - Jan 2017

Keywords

anticoagulation
rivaroxaban
apixaban
venous thromboembolism
ACUTE VENOUS THROMBOEMBOLISM
RANDOMIZED CONTROLLED-TRIALS
VITAMIN-K ANTAGONISTS
ORAL ANTICOAGULANTS
DOUBLE-BLIND
OPEN-LABEL
METAANALYSIS
CANCER
RIVAROXABAN
DABIGATRAN

Access to Document

10.1016/j.thromres.2016.11.014

Cite this

Beyer-Westendorf, J., Lensing, A. W. A., Arya, R., Bounameaux, H., Cohen, A. T., Wells, P. S., Middeldorp, S., Verhamme, P., Hughes, R., Kucher, N., Pap, A. F., Trajanovic, M., Prins, M. H., Prandoni, P., & Weitz, J. I. (2017). Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials. Thrombosis Research, 149, 29-37. https://doi.org/10.1016/j.thromres.2016.11.014

Beyer-Westendorf, Jan ; Lensing, Anthonie W. A. ; Arya, Roopen ; Bounameaux, Henri ; Cohen, Alexander T. ; Wells, Philip S. ; Middeldorp, Saskia ; Verhamme, Peter ; Hughes, Rodney ; Kucher, Nils ; Pap, Akos F. ; Trajanovic, Mila ; Prins, Martin H. ; Prandoni, Paolo ; Weitz, Jeffrey I. / Choosing wisely : The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials. In: Thrombosis Research. 2017 ; Vol. 149. pp. 29-37.

@article{301d3eddebbd4b1897032bf65fc8413e,

title = "Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials",

keywords = "anticoagulation, rivaroxaban, apixaban, venous thromboembolism, ACUTE VENOUS THROMBOEMBOLISM, RANDOMIZED CONTROLLED-TRIALS, VITAMIN-K ANTAGONISTS, ORAL ANTICOAGULANTS, DOUBLE-BLIND, OPEN-LABEL, METAANALYSIS, CANCER, RIVAROXABAN, DABIGATRAN",

author = "Jan Beyer-Westendorf and Lensing, {Anthonie W. A.} and Roopen Arya and Henri Bounameaux and Cohen, {Alexander T.} and Wells, {Philip S.} and Saskia Middeldorp and Peter Verhamme and Rodney Hughes and Nils Kucher and Pap, {Akos F.} and Mila Trajanovic and Prins, {Martin H.} and Paolo Prandoni and Weitz, {Jeffrey I.}",

year = "2017",

month = jan,

doi = "10.1016/j.thromres.2016.11.014",

language = "English",

volume = "149",

pages = "29--37",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Science",

}

Beyer-Westendorf, J, Lensing, AWA, Arya, R, Bounameaux, H, Cohen, AT, Wells, PS, Middeldorp, S, Verhamme, P, Hughes, R, Kucher, N, Pap, AF, Trajanovic, M, Prins, MH, Prandoni, P & Weitz, JI 2017, 'Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials', Thrombosis Research, vol. 149, pp. 29-37. https://doi.org/10.1016/j.thromres.2016.11.014

Choosing wisely : The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials. / Beyer-Westendorf, Jan; Lensing, Anthonie W. A.; Arya, Roopen; Bounameaux, Henri; Cohen, Alexander T.; Wells, Philip S.; Middeldorp, Saskia; Verhamme, Peter; Hughes, Rodney; Kucher, Nils; Pap, Akos F.; Trajanovic, Mila; Prins, Martin H.; Prandoni, Paolo; Weitz, Jeffrey I.

In: Thrombosis Research, Vol. 149, 01.2017, p. 29-37.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Choosing wisely

T2 - The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials

AU - Beyer-Westendorf, Jan

AU - Lensing, Anthonie W. A.

AU - Arya, Roopen

AU - Bounameaux, Henri

AU - Cohen, Alexander T.

AU - Wells, Philip S.

AU - Middeldorp, Saskia

AU - Verhamme, Peter

AU - Hughes, Rodney

AU - Kucher, Nils

AU - Pap, Akos F.

AU - Trajanovic, Mila

AU - Prins, Martin H.

AU - Prandoni, Paolo

AU - Weitz, Jeffrey I.

PY - 2017/1

Y1 - 2017/1

KW - anticoagulation

KW - rivaroxaban

KW - apixaban

KW - venous thromboembolism

KW - ACUTE VENOUS THROMBOEMBOLISM

KW - RANDOMIZED CONTROLLED-TRIALS

KW - VITAMIN-K ANTAGONISTS

KW - ORAL ANTICOAGULANTS

KW - DOUBLE-BLIND

KW - OPEN-LABEL

KW - METAANALYSIS

KW - CANCER

KW - RIVAROXABAN

KW - DABIGATRAN

U2 - 10.1016/j.thromres.2016.11.014

DO - 10.1016/j.thromres.2016.11.014

M3 - Article

C2 - 27886530

VL - 149

SP - 29

EP - 37

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -